Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Ensure Timely Monitoring for Antidepressant Medication

Chevy Chase, Maryland Survey Completed on 04-28-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A review of the medical record for Resident #16 revealed an active order for Bupropion, an antidepressant, to be administered once daily starting on 3/24/2025. Despite the known need for monitoring due to potential side effects associated with antidepressant use, there was no order for antidepressant monitoring documented in the resident's medical record until 4/16/2025. An interview with the Director of Nursing confirmed that the facility's expectation is for side effect monitoring to be ordered when an antipsychotic is prescribed. This lapse resulted in a period during which the resident was receiving Bupropion without the required monitoring for side effects.

An unhandled error has occurred. Reload 🗙